Custom service
Cyclic Peptide Design Services
Design cyclic scaffolds around a binding or stability objective
The service is built around structure-guided ring design. Depending on the molecule we may move to turn-motif selection or cyclization-site optimization to improve stability, loading or yield, and every batch is released with design dossier with candidate sequences and routes.
Because Cyclic Peptide Designs projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.
Converting linear binders into cyclic analogs
Designing macrocycles from peptide hits
Designs with no structural or sequence starting point
Cycles whose ring size is known to be geometrically uncloseable
Cyclic products are released against connectivity, not mass alone. MS/MS fragmentation confirms the ring closure, and where multiple topologies are possible the target isomer is isolated and its ratio reported. Protease-stability data are available as an add-on.
Service Highlights
- Structure-guided ring design as the default route, with turn-motif selection held as a proven fallback
- Cyclization-site optimization worked into the design where the application requires it
- Cyclization strategy (head-to-tail, disulfide, lactam, thioether) chosen from a feasibility screen, not fixed by habit
- Analytical confirmation of every intermediate before the final release
- Cyclic/linear and topological isomers separated and reported, with the target isomer identified by MS/MS
- Design dossier with candidate sequences and routes delivered with a complete conjugation or synthesis certificate
How the work runs
Precursor design
Linear precursor, cyclization sites and protecting strategy are designed around the Cyclic Peptide Design Services ring size.
Linear assembly
The precursor chain is assembled with Fmoc chemistry and structure-guided ring design where relevant.
Cyclization
Ring closure is executed by turn-motif selection under screened dilution and activation conditions.
Isomer separation
RP-HPLC resolves cyclic/linear and topological isomers; the target isomer is collected.
Characterization
Connectivity, purity and identity are confirmed by MS/MS and HPLC against the specification.
Release
Design dossier with candidate sequences and routes is documented and released after QC sign-off.
Specifications & timeline
- Turnaround
- 3–6 weeks
- Typical scale
- 1 – 200 mg cyclic peptide
- Chemistry options
- structure-guided ring design; turn-motif selection; cyclization-site optimization
- Deliverable
- Design dossier with candidate sequences and routes
- QC package
- HPLC purity, MS/MS connectivity proof, isomer ratio, DMSO solubility
- Shipping
- Ambient with desiccant; blue ice for sensitive motifs
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.